Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
64% of large firms say GLP-1 drug coverage moderately or significantly impacted their prescription drug spending Similar to the findings on use, 43% of firms with 1,000 to 4,999 workers, and 66% of firms with 5,000 or more workers, say that covering GLP-1 agonists for weight loss had a significant impact on the health plans prescription drug spending
retatrutide carries GLP-1 class risks including nausea, gallbladder disease, pancreatitis, and delayed gastric emptying affecting oral medicine absorption
These can include mild soreness or bruising at the injection site, dizziness, or in very rare cases, allergic reactions
See our disclosure page for details
Our GHK-Cu is verified at 99% purity via third-party HPLC analysis
Our nursing team trains you in clinic until self-injection feels routine
US$ 27.04
US$ 20.84
US$ 20.14
US$ 28.80
US$ 21.34
US$ 25.41
